This biohybrid device generates electrical energy using light-activated ion channels in designer cells, suggesting a new approach for powering bioelectronic implants.
Herein, an implantable, miniature biohybrid device has been developed that utilizes light-dependent ion-gradient formation by genetically engineered human designer cells, expressing light-activated ion channels and proton pumps to generate electrical potential and deliver electrical energy. These designer cells are cultured in custom-designed polycarbonate chambers, connected by electrodes and separated from an ion reservoir by a proton-selective Nafion membrane. Upon illumination, the light-activated channels and pumps on the designer cells establish a sustained proton gradient across the Nafion membrane, which drives an electrical current in the external circuit. When exposed to simulated ambient sunlight of 3 mW cm- 2 of intensity, a single solar collection device (SCD), containing these designer cells, appropriately sized for subcutaneous implantation in mice, generates an electrical potential of ≈0.4 V. By connecting multiple SCDs in series and increasing the cell suspension volume, the output can be scaled up sufficiently to power a commercial light-emitting diode. Thus, this study demonstrates the feasibility of a photovoltaic system based on optogenetically engineered mammalian cells for powering bioelectronic implants or wearable devices.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: